Deal Type

Clario, a provider of endpoint data solutions to the clinical trial industry, has agreed the acquisition of the electronic clinical outcomes assessments (eCOA) business...

Global private equity healthcare specialist Archimed has acquired BioVendor Group, a developer and manufacturer of immunoassays, recombinant proteins, antibodies and endotoxin-removal products. The acquisition expands...

CVC has held the final close of CVC Strategic Opportunities III with total commitments of €4.61bn (US$5bn). The size matches that of its predecessor,...

Portugal-based FairJourney Biologics, a company involved in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South...

Frankfurt-listed global healthcare company, Fresenius SE, has taken advantage of a buoyant stock market to sell 10.6 million existing shares of Fresenius Medical Care...

France-based Sofinnova Partners, a European venture capital firm in life sciences, has raised €1.2bn (US$1.3bn) across its platform of investment strategies over the past...

LSE-listed Avacta Therapeutics, a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumour payloads directly to the tumour, has agreed...

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, has launched with the closing...

Paris-listed Eurazeo, a European investment group has held the final close of its Eurazeo Capital V programme (EC-V) with c. €3bn (US$3.25bn) in aggregate...

Asker Healthcare Group, a Sweden-based provider of medical products and solutions, is intending to launch an IPO on Nasdaq Stockholm. The offering, which will...